← Back to Search

Experimental (PLR) for Endometriosis

N/A
Waitlist Available
Research Sponsored by BC Women's Hospital & Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Summary

This trial is testing two tools to help women with endometriosis who have painful sex. One tool is a set of silicone rings that limit how deep penetration goes, and the other is a device for checking pain levels at home. These tools aim to make sex less painful and help women understand their pain better.

Eligible Conditions
  • Endometriosis
  • Painful Intercourse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of the phallus length reducer (PLR)
Secondary study objectives
Acceptability of self-measurement of dyspareunia
Change in level of general anxiety (GAD-7)
Mental Depression
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Experimental (PLR)Experimental Treatment2 Interventions
Participants will be given the OhNut Phallus Length Reducer (PLR) for use during the study period.
Group II: Control (Waitlist)Experimental Treatment1 Intervention
Participants will not have a PLR during the study period. They will be placed on a waitlist to receive the PLR at the end of the study period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phallus Length Reducer
2021
N/A
~30

Find a Location

Who is running the clinical trial?

BC Women's Hospital & Health CentreLead Sponsor
13 Previous Clinical Trials
1,009,178 Total Patients Enrolled
5 Trials studying Endometriosis
1,005,212 Patients Enrolled for Endometriosis
~7 spots leftby Sep 2025